Mark Hurley is currently the chair and non-executive director at Biofortuna Limited, a company known for its expertise in genomic services and contract manufacturing. With over 15 years of experience, Mark has successfully led multiple businesses, including Novolytics Limited and BioEDEN Limited, through to profitable exits. They also contributed to the growth of Intechnica and Origin Broadband. Mark has held various board positions in innovative tech companies and is an active investor in venture capital-backed enterprises.
This person is not in the org chart
This person is not in any teams
This person is not in any offices